These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28623739)

  • 41. Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients.
    Sultani R; Tong DC; Peverelle M; Lee YS; Baradi A; Wilson AM
    Heart Lung Circ; 2020 Mar; 29(3):414-421. PubMed ID: 31014557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Triglyceride to high-density lipoprotein cholesterol ratio as a predictor of long-term mortality in patients with coronary artery disease after undergoing percutaneous coronary intervention: a retrospective cohort study.
    Dai XY; Zheng YY; Tang JN; Yang XM; Guo QQ; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Zhang ZL; Zheng RJ; Zhang JY
    Lipids Health Dis; 2019 Dec; 18(1):210. PubMed ID: 31801554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina.
    Caselli C; De Caterina R; Smit JM; Campolo J; El Mahdiui M; Ragusa R; Clemente A; Sampietro T; Clerico A; Liga R; Pelosi G; Rocchiccioli S; Parodi O; Scholte A; Knuuti J; Neglia D;
    Sci Rep; 2021 Oct; 11(1):20714. PubMed ID: 34671067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The characteristics of high density lipoprotein cholesterol and the relationship between high density lipoprotein cholesterol and the severity of coronary artery lesions in young men with acute myocardial infarction].
    Li Z; Tao Y; Huang J; Wang Q; Zhang DH; Wu XY
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1458-62. PubMed ID: 24029567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-density lipoproteins and coronary artery disease: a single-center cohort study.
    Schaffer A; Verdoia M; Barbieri L; Aprami TM; Suryapranata H; Marino P; Luca GD;
    Angiology; 2014 Sep; 65(8):696-702. PubMed ID: 24052525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol in coronary artery disease].
    Halilović E; Kabil E; Ljuca F; Nuhbegović S; Berbić S; Halilović E
    Med Arh; 2007; 61(2 Suppl 1):7-10. PubMed ID: 21553440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
    Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
    Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
    Liting P; Guoping L; Zhenyue C
    Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease.
    Nishikura T; Koba S; Yokota Y; Hirano T; Tsunoda F; Shoji M; Hamazaki Y; Suzuki H; Itoh Y; Katagiri T; Kobayashi Y
    J Atheroscler Thromb; 2014; 21(8):755-67. PubMed ID: 24717762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
    Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
    Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal cutoff value of high-density lipoprotein cholesterol for predicting coronary artery disease in Taiwanese population.
    Huang YC; Ho CC; Lin PT; Lee BJ; Lai CH; Liaw YP
    Nutr Res; 2010 Jan; 30(1):21-6. PubMed ID: 20116656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases.
    Koba S; Hirano T; Ito Y; Tsunoda F; Yokota Y; Ban Y; Iso Y; Suzuki H; Katagiri T
    Atherosclerosis; 2006 Nov; 189(1):206-14. PubMed ID: 16414053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significance of serum high-density lipoprotein cholesterol levels for diagnosis of coronary stenosis as determined by MDCT in patients with suspected coronary artery disease.
    Shiga Y; Miura S; Mitsutake R; Kawamura A; Uehara Y; Saku K
    J Atheroscler Thromb; 2010 Aug; 17(8):870-8. PubMed ID: 20467190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
    Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
    Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discordance of Low-Density Lipoprotein Cholestrol and Non-High-Density Lipoprotein Cholestrol and Coronary Artery Disease Severity.
    Kurmus O; Erkan AF; Ekici B; Aslan T; Eren M
    Arq Bras Cardiol; 2020 Mar; 114(3):469-475. PubMed ID: 32049158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of Association between High-Density Lipoprotein Cholesterol and Angiographic Coronary Lesion Severity in Chinese Patients with Low Background Low-Density Lipoprotein Cholesterol.
    Su CS; Chen KJ; Sheu WH; Yang YL; Liu TJ; Chang WC; Wang KY; Lee WL
    Acta Cardiol Sin; 2015 Nov; 31(6):528-35. PubMed ID: 27122918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contributors to newly developed coronary artery disease in patients with a previous history of percutaneous coronary intervention beyond the early phase of restenosis.
    Endo A; Yoshida Y; Kageshima K; Sato H; Suga T; Nasu H; Takahashi N; Tanabe K
    Intern Med; 2014; 53(8):819-28. PubMed ID: 24739601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease.
    You J; Wang Z; Lu G; Chen Z
    Biomed Res Int; 2020; 2020():7146028. PubMed ID: 32219140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.